Related Experiment Video
Updated: Mar 24, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
Short-course PET based simultaneous integrated boost for locally advanced cervical cancer
Marius Røthe Arnesen1,2, Bernt Louni Rekstad3, Caroline Stokke4,5
1Department of Medical Physics, The Norwegian Radium Hospital, Oslo University Hospital, PO Box 4953, Nydalen, N-0424, Oslo, Norway. mariua@ous-hf.no.
This study shows that using 18F-FDG PET imaging to guide radiotherapy dose escalation in large, locally advanced cervical cancers (LACC) is feasible. This approach may improve tumor shrinkage and local control, potentially benefiting patients with larger tumors.
Area of Science:
- Radiation Oncology
- Medical Imaging
- Oncology
Background:
- Large, locally advanced cervical cancers (LACC) present significant treatment challenges.
- Current treatments require optimization for improved outcomes.
Purpose of the Study:
- To evaluate the feasibility of using 18F-FDG PET imaging for planning a simultaneous integrated boost (SIB) in external beam radiotherapy for LACC.
- To assess the potential for increased tumor shrinkage and local control with this SIB strategy.
Main Methods:
- Ten LACC patients with pre-treatment 18F-FDG PET/CT scans were analyzed.
- In silico dose escalation of the 18F-FDG avid tumor volume (MTV50) to 2.8 Gy/fraction for the first 10 fractions (SIB).
- Photon (VMAT) and proton (IMPT) therapy plans were generated and compared, with organ at risk (OAR) doses simulated.
Main Results:
- Dose escalation to MTV50 was achievable with both VMAT and IMPT, meeting dose constraints.
- A marginal increase in OAR doses was observed with the SIB approach, with mean differences below 2%.
- IMPT showed reduced low-to-intermediate OAR doses compared to VMAT but no added benefit for dose escalation.
Conclusions:
- Planning dose escalation for LACC based on FDG-avid volumes is feasible.
- This strategy may enhance tumor shrinkage prior to brachytherapy, offering clinical value for large tumors.
More Related Videos
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Related Concept Videos
Treatment Resistant Cancers
Treatment Resistent Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...